BCAX vs OMCL
Comparison between Bicara Therapeutics Inc (BCAX, Company) and Omnicell Inc (OMCL, Company).
Both BCAX and OMCL are from the Healthcare sector.
BCAX vs OMCL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BCAX
$1.70B
OMCL
$1.70B
Max Drawdown
Winner
BCAX
67.82%
OMCL
86.67%
Sharpe Ratio
Winner
BCAX
1.89
OMCL
0.51
5Y Beta
BCAX
1.38
Winner
OMCL
0.95
Industry
BCAX
Biotechnology
OMCL
Health Information Services
P/E Ratio
Winner
BCAX
-9.64
OMCL
43.27
Forward P/E
BCAX
N/A
OMCL
29.50
PEG Ratio
BCAX
N/A
OMCL
0.60
5Y EPS CAGR
BCAX
N/A
OMCL
-9.16%
Debt to Equity
BCAX
0.00%
OMCL
0.00%
Free Cash Flow Yield
BCAX
-6.87%
Winner
OMCL
8.41%
P/S Ratio
BCAX
N/A
OMCL
1.36
P/B Ratio
BCAX
3.46
Winner
OMCL
1.31
BCAX vs OMCL - Historical Returns
Returns include dividend reinvestment.
1M
Winner
BCAX
-7.70%
OMCL
-17.02%
3M
Winner
BCAX
+21.52%
OMCL
-15.05%
6M
Winner
BCAX
+82.68%
OMCL
-0.70%
1Y
Winner
BCAX
+175.10%
OMCL
+18.63%
5Y(CAGR)
BCAX
N/A
OMCL
-25.26%
10Y(CAGR)
BCAX
N/A
OMCL
-0.34%
Max(CAGR)
Winner
BCAX
+10.02%
OMCL
+5.91%
BCAX vs OMCL - Annual Returns (2001 - 2026)
Returns include dividend reinvestment.
| Year | BCAX | OMCL |
|---|---|---|
| 2026 | +71.31% | -18.45% |
| 2025 | -0.56% | +2.21% |
| 2024 | -25.59% | +19.26% |
| 2023 | N/A | -26.99% |
| 2022 | N/A | -72.07% |
| 2021 | N/A | +51.31% |
| 2020 | N/A | +47.10% |
| 2019 | N/A | +36.31% |
| 2018 | N/A | +23.72% |
| 2017 | N/A | +40.99% |
| 2016 | N/A | +16.49% |
| 2015 | N/A | -3.48% |
| 2014 | N/A | +32.11% |
| 2013 | N/A | +66.21% |
| 2012 | N/A | -11.12% |
| 2011 | N/A | +13.46% |
| 2010 | N/A | +21.12% |
| 2009 | N/A | -9.24% |
| 2008 | N/A | -54.76% |
| 2007 | N/A | +47.16% |
| 2006 | N/A | +54.48% |
| 2005 | N/A | +10.96% |
| 2004 | N/A | -32.72% |
| 2003 | N/A | +440.00% |
| 2002 | N/A | -70.72% |
| 2001 | N/A | +1.60% |
BCAX vs OMCL Drawdown Comparison
The maximum drawdown for BCAX was -67.82%, occurring on Jun 27, 2025. Recovery took 445 trading sessions.
The maximum drawdown for OMCL was -86.67%, occurring on Oct 8, 2002. Recovery took 406 trading sessions.
The current BCAX drawdown is -7.70%. The current OMCL drawdown is -79.95%.
| Rank | BCAX | OMCL |
|---|---|---|
| #1 | -67.82% Sep 17, 2024 - Jun 29, 2026 | -86.67% Dec 5, 2001 - Jul 18, 2003 |
| #2 | -15.33% Jul 7, 2026 - Aug 3, 2026 | -86.59% Nov 23, 2021 - May 7, 2025 |
| #3 | -2.63% Jun 30, 2026 - Jul 7, 2026 | -77.96% Oct 2, 2007 - Oct 31, 2014 |
| #4 | N/A | -72.92% Mar 4, 2004 - Apr 25, 2007 |
| #5 | N/A | -42.27% Sep 6, 2001 - Dec 5, 2001 |
| #6 | N/A | -39.91% Jun 21, 2019 - Nov 9, 2020 |
| #7 | N/A | -37.04% Jul 24, 2015 - Sep 7, 2016 |
| #8 | N/A | -26.42% Oct 24, 2017 - Jul 5, 2018 |
| #9 | N/A | -26.23% Nov 30, 2018 - Feb 11, 2019 |
| #10 | N/A | -24.18% Sep 17, 2003 - Dec 18, 2003 |
| #11 | N/A | -22.77% Sep 7, 2016 - Mar 31, 2017 |
| #12 | N/A | -20.65% Apr 26, 2007 - Jul 20, 2007 |
| #13 | N/A | -17.18% Feb 22, 2019 - Jun 19, 2019 |
| #14 | N/A | -15.41% Sep 27, 2018 - Nov 7, 2018 |
| #15 | N/A | -12.81% Feb 25, 2015 - Apr 6, 2015 |
Correlation
Correlation between BCAX and OMCL is 0.45 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.45
-101
Select Stocks to Compare
Popular: BCAX vs SPYOMCL vs SPY
More Comparisons
Compare with similar stocks